...
首页> 外文期刊>The Veterinary Journal >Does the taking of biopsies affect the metastatic potential of tumours? A systematic review of reports on veterinary and human cases and animal models. [Review]
【24h】

Does the taking of biopsies affect the metastatic potential of tumours? A systematic review of reports on veterinary and human cases and animal models. [Review]

机译:进行活检是否会影响肿瘤的转移潜力?对兽医和人类病例以及动物模型的报告进行系统的审查。 [评论]

获取原文
获取原文并翻译 | 示例
           

摘要

Clinicians and pathologists are sporadically asked by owners whether the taking of tumour biopsies may affect the behaviour of the tumour, including its potential to metastasise. Unfortunately, systematic studies on this subject are unavailable in veterinary medicine, and the aim of this study was to estimate the risk of adverse effects of biopsy taking on tumour progression in animals. A systematic review of veterinary and human case reports and clinical studies as well as experimental animal models of biopsy-induced tumour metastasis was undertaken. There were only two veterinary case reports of needle tract metastases (NTM) following the taking of needle biopsies from urogenital and pulmonary tumours. Seventeen experimental studies found a high incidence of NTM but only a rat osteosarcoma and a hamster squamous carcinoma model showed an increased incidence of distant or regional metastases after incision or excision biopsy. In human medicine, the occurrence of NTM has been reported after the taking of biopsies from mesotheliomas (15%), melanomas (11%) and gall bladder tumours (11%), liver metastases of colon carcinomas (4%) and mammary carcinomas (4%) but an incidence of only <1% for all other tumours. Circulating tumour cells increased immediately after the taking of biopsies from human squamous cell, prostate, breast and hepatocellular carcinomas. Although no increased risk of biopsy-induced distant metastasis has been reported for any type of tumour, this is inconclusive due to a lack of non-biopsied control groups in human studies. Reports of biopsy-induced metastasis in animal tumours indicate that the taking of transcutaneous biopsies from urogenital tumours may be associated with a risk of NTM. However, there is no evidence of a general increase in risk of distant metastases in any tumour type in people or animals. The overall risk therefore appears to be negligible when compared to the valuable information obtained from biopsies in veterinary practice. Copyright Copyright 2011 Elsevier Ltd. All rights reserved.
机译:主人偶尔询问临床医生和病理学家是否进行肿瘤活检可能影响肿瘤的行为,包括转移的可能性。不幸的是,在兽医学上还没有关于该主题的系统研究,并且该研究的目的是估计活检对动物肿瘤进展的不利影响的风险。对兽医和人类病例报告,临床研究以及活检引起的肿瘤转移的实验动物模型进行了系统的综述。在从泌尿生殖道和肺部肿瘤进行活检后,仅有两例兽医病例报告了针道转移(NTM)。十七项实验研究发现NTM的发生率很高,但只有大鼠骨肉瘤和仓鼠鳞状癌模型显示,在进行切开或切除活检后,远处或区域转移的发生率增加。在人类医学中,据报道在对间皮瘤(15%),黑色素瘤(11%)和胆囊肿瘤(11%),结肠癌(4%)和乳腺癌的肝转移进行活检后发现了NTM。 4%),但所有其他肿瘤的发生率仅<1%。从人鳞状细胞癌,前列腺癌,乳腺癌和肝细胞癌进行活检后,循环肿瘤细胞立即增加。尽管没有任何类型的肿瘤活检引起的远处转移的危险的报道,但由于人体研究中缺乏未进行活检的对照组,因此尚无定论。活检引起的动物肿瘤转移的报告表明,从泌尿生殖道肿瘤中进行经皮活检可能与NTM风险有关。但是,没有证据表明人或动物的任何肿瘤类型中远处转移的风险普遍增加。因此,与从兽医活检中获得的宝贵信息相比,总体风险似乎可以忽略不计。版权版权所有2011 ElsevierLtd。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号